BAY 3547922 clinical trials

A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer

This study is looking at a new drug (BAY 3547926) for advanced liver cancer. Researchers want to check its safety, how well it works, and find the best dose. The drug targets cancer cells with a special protein and uses a small amount of radiation to damage them.